Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-29 @ 5:33 AM
Study NCT ID:
NCT04640935
Status:
COMPLETED
Last Update Posted:
2020-11-23
First Post:
2020-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.
Sponsor:
Centre Hospitalier Annecy Genevois
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-05
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-09
First Submit QC Date:
None
Study First Post Date:
2020-11-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-20
Last Update Post Date:
2020-11-23
Last Update Post Date Type:
ACTUAL